Oncology Medical News about Squamous Cell Carcinoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A phase 2 trial of surgery with perioperative INGN 201 (AD5CMV-P53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx
Archives of Otolaryngology, 09/29/09

Yoo GH et al. – This trial demonstrated the feasibility of handling and delivering a very complex gene vector safely in multiple cooperative group institutions without significant incident. Intraoperative INGN 201 gene therapy is technically feasible, but it has many logistical problems when performed in a multi-institutional setting. Regulatory requirements might have hindered accrual in this multi-institutional setting. Disease control seems to be promising; however, no definitive conclusion can be made with this small sample size.

Methods

Phase 2 study
13 individuals
Newly diagnosed
Previously untreated squamous cell carcinoma of the oral cavity oropharynx, larynx, or hypopharynx
Selected stage III or IV disease without distant metastases; and surgically resectable disease

Results

13 patients received surgery and perioperative INGN 201 injections in the primary tumor bed and the ipsilateral neck
3 patients did not receive chemoradiotherapy
1 patient had a grade 2 fistula of the oral cavity
Of the 10 patients with evaluable data, 2 experienced grade 4 adverse events, 1 owing to hypokalemia, hyponatremia, vomiting, leukopenia, and neutropenia and 1 owing to increased aspartate aminotransferase and alanine aminotransferase levels
7 other patients experienced grade 3 adverse events
Estimate of 1-year progression-free survival 92%

<< Previous
Salvage therapy of pretreated advanced breast cancer with...

Next >>
Recent natural selection identifies a genetic variant in a...

Spread of Squamous Cell Carcinoma From the Thumb to the Small Finger via the Flexor Tendon Sheaths
The Journal of Hand Surgery, 11/16/09 Relevance Score: 83%

Squamous cell cancer of the rectum
World Journal of Gastroenterology, 10/01/09 Relevance Score: 82%

Primary cutaneous myxoid spindle cell squamous cell carcinoma: a clinicopathologic study and review of the literature
Journal of Cutaneous Pathology, 10/09/09 Relevance Score: 81%

RalA suppresses early stages of Ras-induced squamous cell carcinoma progression
Oncogene, 10/08/09 Relevance Score: 81%

Nd:YAG laser therapy of carcinoma lip (stage I squamous cell carcinoma): a retrospective evaluation
Indian Journal of Otolaryngology and Head & Neck Surgery, 10/07/09 Relevance Score: 81%